Company: SXTPW
Filing Date: 2025-09-02
Form Type: DEFR14A
Source: 0001213900-25-082789
Chunk: 12

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-09-02
Form: DEFR14A
Chunk 12
---
2 Plan, and ratify the appointment of our independent registered public accounting firm and approve the adjournment of the Annual Meeting. Abstentions will be treated as votes against these proposals. Brokerage firms have authority to vote customers’ unvoted shares held by the firms in street name on the ratification of the appointment of our independent registered public accounting firm and approval of the adjournment of the Annual Meeting. If a broker does not exercise this authority, such broker non-votes will have no effect on the results of this vote. Brokerage firms do not have authority to vote customers’ unvoted shares held by the firms in street name on the approval of the election of directors of the current Board of Directors, approval of an amendment to the 2022 Plan, approval of the amendment to the Certificate of Incorporation and approval to obtain the approval of our stockholders to appoint our independent registered public accounting firm. However, if our stockholders do not ratify the appointment of RBSM LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025, the audit committee of our Board will reconsider its appointment. 6 Q: Is voting confidential? A:We will keep all the proxies, ballots and voting tabulations private. We only let our Inspectors of Election, representatives of Equity Stock Transfer, examine these documents. Management will not know how you voted on a specific proposal unless it is necessary to meet legal requirements. We will, however, forward to management any written comments you make on the proxy card or that you otherwise provide. Q: When will the Company announce the voting results? A:The Company may announce preliminary voting results after the adjournment of the Annual Meeting and will announce the final voting results of the Annual Meeting on a Current Report on Form 8-K filed with the SEC within four business days after the Annual Meeting. Q: Do any directors or officers of the Company have a personal interest in the matter to be acted upon at the Annual Meeting? A:Except for those directors who are nominated for election at the Annual Meeting, no officer or director has any substantial interest, direct or indirect, by security holdings or otherwise in all proposals voted on in Proposal 2, Proposal 3 and Proposal 4 that is not shared by all other stockholders. Q: What if other matters are presented for consideration at the Annual Meeting? A:The Company knows of no other matters to be submitted to the stockholders at the Annual Meeting, other than those described herein. If other